Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)

Market Cap	13.53B +28.3%
Revenue (ttm)	4.00B -6.6%
Net Income	712.56M -1.2%
EPS	0.86 +2.1%
Shares Out	813.76M
PE Ratio	19.39
Forward PE	17.26
Dividend	0.35 (2.06%)
Ex-Dividend Date	May 29, 2025

Volume	8,160,679
Average Volume	15,103,253
Open	16.96
Previous Close	16.63
Day's Range	16.36 - 16.96
52-Week Range	11.90 - 22.62
Beta	0.01
RSI	26.00
Earnings Date	Apr 24, 2026

About SHE:002020

Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products and medical devices in China and internationally. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemirs, antidepressant, cephalosporin, and biopharma products; and API products, including ciprofloxacin, ciprofloxacin hydrochloride, ciprofloxacin lactat...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 3,869
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002020

Financial Performance

In 2024, SHE:002020's revenue was 4.16 billion, an increase of 3.99% compared to the previous year's 4.00 billion. Earnings were 711.96 million, an increase of 15.04%.